Campath and Protonix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Campath (alemtuzumab) and Protonix (pantoprazole sodium). Common drug interactions include vomiting among females and renal failure acute among males.

The phase IV clinical study analyzes what interactions people have when they take Campath and Protonix. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.

What is Campath?

Campath has active ingredients of alemtuzumab. eHealthMe is studying from 4,909 Campath users. Check the latest studies of Campath.

What is Protonix?

Protonix has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 132,658 Protonix users. Check the latest studies of Protonix.



On Jul, 05, 2026

67 people who take Campath and Protonix together, and have interactions are studied.

Campath and Protonix drug interactions.

What are the common drug interactions of Campath and Protonix, by gender? *:

female:

  1. Vomiting
  2. Pyrexia (fever)
  3. Depression
  4. Headache (pain in head)
  5. Muscle spasms (muscle contraction)
  6. Wheezing (a high-pitched whistling sound made while you breath)
  7. Dyspnoea (difficult or laboured respiration)
  8. Chills (felling of cold)
  9. Nausea (feeling of having an urge to vomit)
  10. Pain

male:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  3. Pleural effusion (water on the lungs)
  4. Abdominal distension
  5. Acute respiratory distress syndrome
  6. Ascites (accumulation of fluid in the abdominal cavity)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  9. Blood bilirubin increased
  10. Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Campath and Protonix, by age (0-1 to 60+)? *:

0-1:

  1. Drug ineffective
  2. Electrolyte imbalance
  3. Haematochezia (passage of stools containing blood)

2-9:

  1. Acinetobacter infection (infection by group of bacteria commonly found in soil and water)
  2. Diarrhoea
  3. Diarrhoea haemorrhagic (bloody diarrhoea)
  4. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  5. Haematoma (collection of blood outside the blood vessels)
  6. Pleural effusion (water on the lungs)
  7. Pyrexia (fever)
  8. Septic shock (shock due to blood infection)
  9. Tooth abscess (pus formation in tooth)

10-19:

  1. Blood chloride increased
  2. Glomerulonephritis proliferative (a disorder of the glomeruli (glomerulonephritis), or small blood vessels in the kidneys)
  3. Haematocrit decreased
  4. White blood cell count decreased
  5. Arteriosclerosis (thickening and hardening of arteries)
  6. Blood bicarbonate increased
  7. Blood creatinine increased
  8. Blood potassium increased
  9. Generalised oedema (swelling all over the body)
  10. Injury

20-29:

  1. Hyperglycaemia (high blood sugar)
  2. Leukopenia (less number of white blood cells in blood)
  3. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

30-39:

  1. Pyrexia (fever)
  2. Chills (felling of cold)
  3. Nausea (feeling of having an urge to vomit)
  4. Pain
  5. Hypertension (high blood pressure)
  6. Migraine (headache)
  7. Back pain
  8. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)

40-49:

  1. Asthma
  2. Chest pain
  3. Hemiparesis (weakness on one side of the body)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Dyspepsia (indigestion)
  6. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  7. Vomiting
  8. Depression
  9. Headache (pain in head)
  10. Muscle spasms (muscle contraction)

50-59:

  1. Cytomegalovirus test positive
  2. Dehydration (dryness resulting from the removal of water)
  3. Delayed engraftment
  4. Discomfort
  5. Dysuria (painful or difficult urination)
  6. Endocarditis (inflammation in heart muscle)
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Graft loss (graft failure)
  9. Haematuria (presence of blood in urine)
  10. Haemorrhage urinary tract (bleeding from uterine)

60+:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Syncope (loss of consciousness with an inability to maintain postural tone)
  3. Ascites (accumulation of fluid in the abdominal cavity)
  4. Aspartate aminotransferase increased
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  7. Blood bilirubin increased
  8. Dyspnoea (difficult or laboured respiration)
  9. Haemoglobin decreased
  10. Hypotension (abnormally low blood pressure)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 18 people, 26.87%
  2. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 11 people, 16.42%
  3. High Blood Pressure: 9 people, 13.43%
  4. Pain: 8 people, 11.94%
  5. Diabetes: 6 people, 8.96%
  6. Constipation: 6 people, 8.96%
  7. Stress And Anxiety: 5 people, 7.46%
  8. Leukopenia (less number of white blood cells in blood): 5 people, 7.46%
  9. Glaucoma (increased fluid pressure in the eye with vision loss): 5 people, 7.46%
  10. Bone Marrow Conditioning Regimen: 4 people, 5.97%

* Approximation only. Some reports may have incomplete information.

Do you take Campath and Protonix?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Campath and Protonix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Campath:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Protonix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Campath and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Protonix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on alemtuzumab and pantoprazole sodium (the active ingredients of Campath and Protonix, respectively), and Campath and Protonix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: